These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 10212000

  • 1. Mutation of p53 and K-ras, and loss of heterozygosity of APC in intrahepatic cholangiocarcinoma.
    Kang YK, Kim WH, Lee HW, Lee HK, Kim YI.
    Lab Invest; 1999 Apr; 79(4):477-83. PubMed ID: 10212000
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. High rates of Ki-ras point mutation in both intra- and extra-hepatic cholangiocarcinomas.
    Ohashi K, Tsutsumi M, Nakajima Y, Noguchi O, Okita S, Kitada H, Tsujiuchi T, Kobayashi E, Nakano H, Konishi Y.
    Jpn J Clin Oncol; 1994 Dec; 24(6):305-10. PubMed ID: 7830335
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Allelotype analysis of intrahepatic cholangiocarcinoma.
    Kang YK, Kim YI, Kim WH.
    Mod Pathol; 2000 Jun; 13(6):627-31. PubMed ID: 10874666
    [Abstract] [Full Text] [Related]

  • 10. The incidence of K-ras codon 12 mutations in cholangiocarcinoma detected by polymerase chain reaction technique.
    Wattanasirichaigoon S, Tasanakhajorn U, Jesadapatarakul S.
    J Med Assoc Thai; 1998 May; 81(5):316-23. PubMed ID: 9623030
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Analysis of p53 mutations for a mutational signature in human intrahepatic cholangiocarcinoma.
    Khan SA, Taylor-Robinson SD, Carmichael PL, Habib N, Lemoine NR, Thomas HC.
    Int J Oncol; 2006 May; 28(5):1269-77. PubMed ID: 16596244
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.